Literature DB >> 1857029

The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer.

Q A Wang1, H Gao, Y H Wang, Y L Chen.   

Abstract

The underlying nature of the transitional mucosa adjacent to colorectal cancer is defined and the evidence for and against the statement that this transitional mucosa involves primary premalignant change presented in this article. An association between mucin histochemical changes at the margins of resection and a poorer clinical outcome of patients has been recognized in patients with colorectal cancer after surgery. The retained transitional mucosa at the margins of resection appears to correlate with tumor recurrence and a poorer survival in patients who have undergone radical resection. It is considered that the transitional mucosa adjacent to colorectal cancer and its presence at the margins of resection may be an important prognostic marker for patients with large bowel cancer following radical resection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857029     DOI: 10.1007/bf02470943

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  56 in total

1.  Sialomucins at resection margin and likelihood of recurrence in colorectal carcinoma.

Authors:  N A Habib; P M Dawson; J W Bradfield; R C Williamson; C B Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

2.  High iron diamine-alcian blue mucin profiles in benign, premalignant and malignant colorectal disease.

Authors:  D C Allen; N S Connolly; J D Biggart
Journal:  Histopathology       Date:  1988-10       Impact factor: 5.087

3.  "Transitional mucosa".

Authors:  M I Filipe
Journal:  Histopathology       Date:  1984-07       Impact factor: 5.087

4.  Ultrastructure of the "transitional" mucosa adjacent to large bowel carcinoma.

Authors:  R H Riddell; B Levin
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

5.  Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa. A histochemical study using lectins.

Authors:  J Calderó; E Campo; C Ascaso; J Ramos; M J Panadés; J M Reñé
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Early precancerous modifications in the mucus of human and rat distal colon: a comparative immunohistologic study.

Authors:  J Bara; C Decaens; P Burtin
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

7.  Sialomucins in the assessment of dysplasia and cancer-risk patients with ulcerative colitis treated with colectomy and ileo-rectal anastomosis.

Authors:  M Ehsanullah; M Naunton Morgan; M I Filipe; B Gazzard
Journal:  Histopathology       Date:  1985-02       Impact factor: 5.087

8.  Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon.

Authors:  A K Shamsuddin; L Weiss; P C Phelps; B F Trump
Journal:  J Natl Cancer Inst       Date:  1981-02       Impact factor: 13.506

9.  Efficacy of differential mucin staining for predicting synchronous and metachronous colorectal carcinomas.

Authors:  T A Colacchio; D Dressel; J L Dunn
Journal:  Am J Surg       Date:  1987-01       Impact factor: 2.565

10.  Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study.

Authors:  M I Filipe
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  2 in total

1.  Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas.

Authors:  Marian Grade; B Michael Ghadimi; Sudhir Varma; Richard Simon; Danny Wangsa; Linda Barenboim-Stapleton; Torsten Liersch; Heinz Becker; Thomas Ried; Michael J Difilippantonio
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

2.  p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.

Authors:  Yvonne Wettergren; Elisabeth Odin; Staffan Nilsson; Göran Carlsson; Bengt Gustavsson
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.